Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuromyelitis Optica × eculizumab × Clear all

Phase

Status

Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 4 Recurrence 1 Optic Neuritis 1 Neuromyelitis Optica 1 Myelitis, Transverse 1 Demyelinating Diseases 1

Interventions

ublituximab 1 eculizumab 1 Rituximab 1 Mitoxantrone 1 LFB-R603 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02003144 2022-08-23

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Alexion Pharmaceuticals, Inc.

Phase 3 Completed

119 enrolled 17 charts

Demyelinating Diseases, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡